ReviewGels (Basel, Switzerland)2025
From Basic to Breakthroughs: The Journey of Microfluidic Devices in Hydrogel Droplet Generation.
Review in Gels (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Next-generation biomedical nanorobots: active design, intelligent control, and translational opportunities in regenerative and minimally invasive medicine.Journal of nanobiotechnology · 2026Review
- Microfluidics to Meet Antibiotic Resistance: A Growing Research Frontier.Antibiotics (Basel, Switzerland) · 2025Review
- Overview of Magnetic Hydrogel Fabrication, Its Basic Characteristics, and Potential Uses in Biomedical Engineering.Bioengineering (Basel, Switzerland) · 2025Review
- Alginate Sphere-Based Soft Actuators.Gels (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydrogel particles are essential in biological applications because of their distinctive capacity to retain water and encapsulate active molecules within their three-dimensional structure. Typical particle sizes range from nanometers (10-500 nm) to micrometers (1-500 µm), depending on the specific application and method of preparation. These characteristics render them optimal carriers for the administration of active compounds, facilitating the regulated and prolonged release of pharmaceuticals, including anticancer agents, antibiotics, and therapeutic proteins. Hydrogel particles can exhibit various morphologies, including spherical, rod-shaped, disk-shaped, and core-shell structures. Each shape offers distinct advantages, such as improved circulation time, targeted drug delivery, or enhanced cellular uptake. Additionally, hydrogel particles can be engineered to respond to various stimuli, such as temperature, pH, light, magnetic fields, and biochemical signals. Furthermore, their biocompatibility and capacity to acclimate to many biological conditions make them appropriate for sophisticated applications, including gene treatments, tissue regeneration, and cell therapies. Microfluidics has transformed the creation of hydrogel particles, providing precise control over their dimensions, morphology, and stability. This technique facilitates reproducible and highly efficient production, reducing reagent waste and optimizing drug encapsulation. The integration of microfluidics with hydrogels provides opportunities for the advancement of creative and effective solutions in contemporary medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.